用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022565 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022568 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022554 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-022555 Act: 33 Size: 27 KB 网页链接
$美鼎生物(VIVO)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-022557 Act: 33 Size: 27 KB 网页链接
$美鼎生物(VIVO)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-022558 Act: 33 Size: 27 KB 网页链接
$美鼎生物(VIVO)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-022559 Act: 33 Size: 27 KB 网页链接
$美鼎生物(VIVO)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-022560 Act: 33 Size: 27 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001193125-23-021179 Act: 34 Size: 2 MB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-23-001535 Size: 15 KB 网页链接